تقرير
Long-acting antiretrovirals: research and implementation considerations in Africa.
| العنوان: | Long-acting antiretrovirals: research and implementation considerations in Africa. |
|---|---|
| المؤلفون: | Norcross C; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK. Electronic address: claire.norcross@lshtm.ac.uk., Ombajo LA; Department of Clinical Medicine and Therapeutics, University of Nairobi, Nairobi, Kenya; Center for Epidemiological Modelling and Analysis, University of Nairobi, Nairobi, Kenya., Kassim S; Desmond Tutu Health Foundation, Cape Town, South Africa; Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa., Garrett N; Centre for the AIDS Programme of Research in South Africa (CAPRISA), University of KwaZulu-Natal, Durban, South Africa; Department of Public Health Medicine, School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa., Cresswell FV; Department of Clinical Research, London School of Hygiene & Tropical Medicine, London, UK; Global Health & Infection Department, Brighton & Sussex Medical School, Brighton, UK; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda., Ruzagira E; Medical Research Council/Uganda Virus Research Institute and London School of Hygiene & Tropical Medicine Uganda Research Unit, Entebbe, Uganda; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK. |
| المصدر: | The lancet. HIV [Lancet HIV] 2023 Jul; Vol. 10 (7), pp. e428-e429. |
| نوع المنشور: | Letter; Research Support, Non-U.S. Gov't; Comment |
| اللغة: | English |
| بيانات الدورية: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101645355 Publication Model: Print Cited Medium: Internet ISSN: 2352-3018 (Electronic) Linking ISSN: 23523018 NLM ISO Abbreviation: Lancet HIV Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: [Amsterdam] : Elsevier B.V., [2014]- |
| مواضيع طبية MeSH: | HIV Infections*/drug therapy , HIV Infections*/epidemiology , HIV Infections*/prevention & control , Anti-HIV Agents*/therapeutic use, Humans ; Anti-Retroviral Agents/therapeutic use ; Africa/epidemiology |
| التعليقات: | Comment on: Lancet HIV. 2023 May;10(5):e332-e342. (PMID: 37062293) |
| معلومات مُعتمدة: | MC_UU_00033/1 United Kingdom MRC_ Medical Research Council; MR/K019708/1 United Kingdom MRC_ Medical Research Council |
| المشرفين على المادة: | 0 (Anti-Retroviral Agents) 0 (Anti-HIV Agents) |
| تواريخ الأحداث: | Date Created: 20230707 Date Completed: 20230710 Latest Revision: 20240325 |
| رمز التحديث: | 20240325 |
| DOI: | 10.1016/S2352-3018(23)00134-0 |
| PMID: | 37419566 |
| قاعدة البيانات: | MEDLINE |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 2352-3018 |
|---|---|
| DOI: | 10.1016/S2352-3018(23)00134-0 |